UnitedHealth Group (UNH)
278.91
+0.00 (0.00%)
NYSE · Last Trade: Feb 12th, 8:40 AM EST
Detailed Quote
| Previous Close | 278.91 |
|---|---|
| Open | - |
| Bid | 278.45 |
| Ask | 278.87 |
| Day's Range | N/A - N/A |
| 52 Week Range | 234.60 - 606.36 |
| Volume | 26,832 |
| Market Cap | 252.69B |
| PE Ratio (TTM) | 14.56 |
| EPS (TTM) | 19.2 |
| Dividend & Yield | 8.840 (3.17%) |
| 1 Month Average Volume | 12,270,806 |
Chart
About UnitedHealth Group (UNH)
UnitedHealth Group is a leading diversified health and well-being company that provides a wide range of health care products and services. The company operates through two main segments: UnitedHealthcare, which offers health insurance and health services to individuals and businesses, and Optum, which delivers pharmacy care, health management, and technology solutions. UnitedHealth Group focuses on enhancing health care access, improving health outcomes, and optimizing costs through integrated care solutions and data-driven insights. With a commitment to innovation and quality, the company aims to help people live healthier lives while making the health care system work better for everyone. Read More
News & Press Releases
These three dividend stocks are worth a close look for their solid business quality and attractive payouts.
Via The Motley Fool · February 11, 2026
In a dramatic shift that has caught many Wall Street analysts off guard, the first two weeks of February 2026 have witnessed a historic "Great Rotation" within the equity markets. The Russell 2000 Index (IWM), which tracks domestic small-cap companies, has staged its most aggressive rally in decades, significantly outperforming
Via MarketMinute · February 11, 2026
The S&P 500 Index retreated further from its historic peaks on Wednesday, closing at 6,914.75, a decline of 0.39% for the session. This pullback marks a significant cooling period for a market that only weeks ago, on January 28, 2026, celebrated a record-shattering high of 7,
Via MarketMinute · February 11, 2026
The Dow Jones Industrial Average (DJIA) surrendered its hard-won psychological high ground on Wednesday, February 11, 2026, sliding back below the 50,000-point milestone. The blue-chip index fell 188 points, or 0.38%, to close at 49,999.24, ending a brief tenure above the historic mark and signaling a
Via MarketMinute · February 11, 2026
As the first quarter of 2026 gets underway, the American economic landscape is being fundamentally reshaped by the "One Big Beautiful Bill Act" (OBBBA). Signed into law by President Trump following a heated legislative battle in late 2025, the sweeping fiscal package has begun to filter through the pockets of
Via MarketMinute · February 11, 2026
In a striking display of market divergence, the Dow Jones Industrial Average surged to its third consecutive record high on Tuesday, February 10, 2026, momentarily piercing the 50,609 mark intraday. This milestone marks a significant psychological and technical breakthrough for the "blue-chip" index, which has found a second wind
Via MarketMinute · February 11, 2026
Two of the stocks seem like good buys -- the other has fallen by nearly half.
Via The Motley Fool · February 11, 2026
The Dow Jones Industrial Average has reached a summit once thought to be years away, officially crossing the 50,000-point threshold in a historic trading session on February 6, 2026. This milestone represents more than just a psychological victory for Wall Street; it serves as a definitive signal that the
Via MarketMinute · February 11, 2026
As of February 11, 2026, Humana Inc. (NYSE: HUM) finds itself at a historic crossroads. Once the darling of the managed care sector, the Louisville-based insurer is currently navigating a "perfect storm" of regulatory tightening, rising medical utilization, and a catastrophic decline in quality bonus payments. Today’s research deep-dive follows a volatile morning on Wall [...]
Via Finterra · February 11, 2026
While profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Via StockStory · February 10, 2026
In a pivotal earnings report delivered on February 10, 2026, CVS Health (NYSE: CVS) showcased a complex narrative of financial resilience and operational headwinds. While the healthcare giant posted record-breaking revenue of $402.1 billion for the full year 2025, surpassing Wall Street expectations, its stock dipped nearly 2.5%
Via MarketMinute · February 10, 2026
Via Benzinga · February 10, 2026
Shares of insurance brokerage firm Arthur J. Gallagher (NYSE:AJG) fell 9.4% in the afternoon session after OpenAI launched a suite of insurance-native applications within its ChatGPT App Library, posing a direct threat to the traditional brokerage model.
Via StockStory · February 9, 2026
The January Consumer Price Index (CPI) report, scheduled for release by the Bureau of Labor Statistics (BLS) on Friday, February 13, 2026, is being viewed as a critical "litmus test" for the Federal Reserve’s "soft landing" narrative. Following a period of significant economic volatility in late 2025, including a
Via MarketMinute · February 9, 2026
The Dow Jones Industrial Average (DJIA) achieved a monumental milestone on Friday, February 6, 2026, closing above the 50,000 mark for the first time in history. The index finished the week at 50,115.67, gaining over 1,200 points in a single session to cap off a historic
Via MarketMinute · February 9, 2026
In a move that marks a definitive shift in the American pharmaceutical supply chain, The Cigna Group (NYSE: CI) has reached a comprehensive settlement with the Federal Trade Commission (FTC) to resolve a contentious lawsuit regarding the pricing of insulin. Announced in early February 2026, the agreement effectively ends years
Via MarketMinute · February 9, 2026
The U.S. financial markets are entering a period of high-stakes anticipation as investors wait for the Bureau of Labor Statistics to release the January employment report this Wednesday morning. Originally scheduled for the first Friday of the month, the release was pushed back due to a brief but disruptive
Via MarketMinute · February 9, 2026
The stock has already declined 16% this year.
Via The Motley Fool · February 9, 2026
The healthcare landscape in early 2026 is defined by a shift from unrestrained growth to tactical consolidation. At the center of this transition sits UnitedHealth Group (NYSE: UNH), a behemoth that has navigated a tumultuous 24 months marked by massive cyber-disruptions, leadership overhauls, and intensifying federal scrutiny. Today, February 9, 2026, the company finds itself [...]
Via Finterra · February 9, 2026
Two top Berkshire Hathaway holdings have strong comeback potential, but another one should be avoided for now.
Via The Motley Fool · February 8, 2026
Retirees should brace themselves for both positive and negative changes to Medicare this year.
Via The Motley Fool · February 8, 2026
Recent Medicare Advantage news may mean disappointing updates to guidance.
Via The Motley Fool · February 7, 2026
The managed care sector was sent into a tailspin on Friday as Molina Healthcare (NYSE: MOH) saw its market capitalization evaporate in a historic sell-off. Shares of the Long Beach-based insurer plummeted 28% to $127.16 after the company issued a 2026 earnings forecast that was not just a miss,
Via MarketMinute · February 6, 2026
Michael Burry says he’s happy with MOH stock, even as Molina Healthcare stock crumbles 25% on disappointing guidance. But are MOH shares really worth buying today?
Via Barchart.com · February 6, 2026
In a week defined by high-stakes political theater and a brief but disruptive lapse in federal operations, Washington has managed to pull back from the edge of a total collapse—though only partially. On February 3, 2026, a $1.2 trillion appropriations package was signed into law, ending a four-day
Via MarketMinute · February 6, 2026